Dalby Helene R, Erichsen Rune, Gotschalck Kaare A, Emmertsen Katrine J
Department of Surgery, Randers Regional Hospital, Randers, Denmark.
Department of Clinical Epidemiology, Aarhus University Hospital & Aarhus University, Aarhus, Denmark.
Int J Colorectal Dis. 2025 May 17;40(1):123. doi: 10.1007/s00384-025-04915-9.
The ideal treatment for chronic and recurrent colonic diverticular disease (crDD) remains unresolved, partly due to lacking evidence regarding surgical safety. This study evaluated 90-day reoperation and mortality rates following elective surgery for crDD and explored predictors for reoperation and mortality.
This national cohort study included all patients with crDD undergoing elective colonic resection or stoma formation in Denmark from 1996-2021. Outcomes were the 90-day cumulative incidence proportion (CIP) of reoperation and mortality, and predictors were explored in Cox proportional hazard models.
Among 35,174 patients with crDD, 3,584 (10%) underwent elective surgery. The 90-day reoperation rate was 18.0%; mortality was 1.6%. During the 25-year period, the reoperation rate declined 30%, from 19.5% to 13.8%, and mortality declined 74%, from 2.7% to 0.7%. Among 2,942 patients with colonic resection and no stoma formation, the reoperation rate due to anastomotic leak was 3.0% overall and 0.9% in the most recent years. Mortality was 18 times higher in patients aged ≥ 80 years versus those aged < 60 years (CIP 8.0% versus 0.4%). The reoperation rate was increased in patients with ≥ 4 hospital contacts or ≥ 3 admissions compared to patients with fewer contacts, while mortality was not associated with the number of hospital contacts before surgery.
Elective surgery in crDD was safe with careful patient selection. The risk of reoperation due to anastomotic leak was very low. Patients with most hospital contacts had an increased reoperation rate, supporting consideration for elective surgery early in patients with disabling diverticular disease.
慢性复发性结肠憩室病(crDD)的理想治疗方法仍未确定,部分原因是缺乏手术安全性的证据。本研究评估了crDD择期手术后90天的再次手术率和死亡率,并探讨了再次手术和死亡的预测因素。
这项全国队列研究纳入了1996年至2021年在丹麦接受crDD择期结肠切除术或造口术的所有患者。结局指标为再次手术和死亡的90天累积发病率比例(CIP),并在Cox比例风险模型中探索预测因素。
在35174例crDD患者中,3584例(10%)接受了择期手术。90天再次手术率为18.0%;死亡率为1.6%。在这25年期间,再次手术率下降了30%,从19.5%降至13.8%,死亡率下降了74%,从2.7%降至0.7%。在2942例接受结肠切除术且未造口的患者中,因吻合口漏导致的再次手术率总体为3.0%,近年来为0.9%。≥80岁患者的死亡率比<60岁患者高18倍(CIP分别为8.0%和0.4%)。与就诊次数较少的患者相比,就诊≥4次或住院≥3次的患者再次手术率增加,而死亡率与术前住院次数无关。
通过仔细选择患者,crDD的择期手术是安全的。因吻合口漏导致再次手术的风险非常低。就诊次数最多的患者再次手术率增加,这支持对患有致残性憩室病的患者尽早考虑择期手术。